Global Anti-inflammatory Therapeutics Market Growth (Status and Outlook) 2024-2030

2024

Global Anti-inflammatory Therapeutics Market Growth (Status and Outlook) 2024-2030

Name: Global Anti-inflammatory Therapeutics Market Growth (Status and Outlook) 2024-2030
Creator: Bonafide Research
License: https://www.bonafideresearch.com/license_information

Anti-inflammatory Therapeutics, valued at US$ 108.14 billion in 2023, are projected to reach US$ 166.15 billion by 2030, with a 6.3% CAGR attributed to growing demand in downstream

Bonafide Trust
04-01-2024
Pages : 109
Figures : 83
Tables : 112
Region : Global
Category : Lifescience
Healthcare

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

According to Publisher’s latest study, the global Anti-inflammatory Therapeutics market size was valued at US$ 108140 million in 2023. With the growing demand in the downstream market, the Anti-inflammatory Therapeutics is forecast to a readjusted size of US$ 166150 million by 2030 with a CAGR of 6.3% during the review period.

Market Overview

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

The research report highlights the growth potential of the global Anti-inflammatory Therapeutics market. Anti-inflammatory Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Anti-inflammatory Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Anti-inflammatory Therapeutics market.

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.

Key Features:
The report on the Anti-inflammatory Therapeutics market reflects various aspects and provides valuable insights into the industry.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Research Consultant

Market Size and Growth: The research report provides an overview of the current size and growth of the Anti-inflammatory Therapeutics market. It may include historical data, market segmentation by Type (e.g., Anti-inflammatory Biologics, Non-Steroidal Anti-inflammatory Drugs (NSAIDs)), and regional breakdowns.

Market Drivers: Growing Prevalence of Inflammatory Diseases: Around the world, the prevalence of chronic inflammatory conditions such as asthma, inflammatory bowel disease, and rheumatoid arthritis is rising. The rising frequency and prevalence of these disorders are caused by several causes, including changing lifestyles, ageing populations, and environmental variables. Effective anti-inflammatory therapies are therefore in greater demand to control symptoms and enhance patient outcomes.
Technological Developments in Drug Discovery, Molecular Biology, and Immunology: These developments have produced novel anti-inflammatory treatments. These developments include the identification of new therapeutic targets, the creation of biological medicines, and the improvement of small-molecule medications. The therapy landscape for inflammatory illnesses has changed dramatically with the advent of biologic treatments, such as cytokine inhibitors and monoclonal antibodies, which provide targeted approaches with better safety and effectiveness profiles.

Extending Therapeutic Indications: The potential of anti-inflammatory medicines to treat a wide range of disorders outside of typical inflammatory diseases is being researched more and more. Neurodegenerative conditions (such as multiple sclerosis, and Alzheimer's disease), cardiovascular conditions (such as atherosclerosis, and myocarditis), and metabolic conditions (such as diabetes, and obesity) are among the illnesses for which therapeutic indications have been expanded. The growing interest in investigating anti-inflammatory therapies for these ailments is a result of researchers discovering the significance of inflammation in a variety of diseases, which is propelling market expansion and innovation.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

Challenges- Safety Concerns: Several anti-inflammatory drugs, especially corticosteroids and NSAIDs, have been linked to side effects such as immunosuppression, gastrointestinal bleeding, and cardiovascular problems. One of the ongoing challenges in the development and application of anti-inflammatory therapies is striking a balance between safety and efficacy.

High Treatment Costs: Although very successful, biological medicines can be expensive to administer, which can prevent some patients and healthcare systems from receiving them. The goal of cost reduction techniques is to promote patient access to biologic medicines while addressing affordability concerns. These tactics include biosimilar development and reimbursement rules.

Drug Resistance and Tolerance: Extended use of some anti-inflammatory drugs may result in drug resistance or tolerance, which may require changing treatments, adjusting dosages, or using combination treatments to keep the medication effective. Research and clinical practice are continuously focused on strategies to reduce resistance and enhance treatment effects.

Regulatory and Market Access Challenges: The accessibility and cost of anti-inflammatory medicines in various markets are influenced by regional differences in regulatory requirements, market access obstacles, and reimbursement practices. To resolve differences in treatment access, regulatory requirements should be harmonized and equitable access efforts should be implemented.

Technological Developments: The research report can delve into the latest technological developments in the Anti-inflammatory Therapeutics industry. This includes advancements in Anti-inflammatory Therapeutics technology, Anti-inflammatory Therapeutics new entrants, Anti-inflammatory Therapeutics new investment, and other innovations that are shaping the future of Anti-inflammatory Therapeutics.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Anti-inflammatory Therapeutics market. It includes factors influencing customers' purchasing decisions, and preferences for Anti-inflammatory Therapeutics products.

Government Policies and Incentives: The research report analyses the impact of government policies and incentives on the Anti-inflammatory Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting the Anti-inflammatory Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provides market forecasts and outlook for the Anti-inflammatory Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The worldwide anti-inflammatory medicines market is a dynamic environment with lots of room for innovation and better patient care. Targeting inflammatory pathways precisely is made possible by biological medicines and targeted techniques, which offer the promise of increased efficacy and reduced adverse effects. Treatments can be customized for each patient, improving results and treatment choices, when combined with personalized medicine and biomarker research. Targeted medication delivery is another benefit of using cutting-edge drug delivery systems, which also minimizes adverse effects and maximizes therapeutic results. These opportunities drive the market for anti-inflammatory medicines and open the door for developments in patient-centred care and treatment modalities.

Market Segmentation:
The Anti-inflammatory Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
1. Segmentation by type
• Anti-inflammatory Biologics
• Non-steroidal anti-inflammatory Drugs (NSAIDs)
• Corticosteroids
• Others
2. Segmentation by application
• Arthritis
• Respiratory Diseases
• Dermatology
• Gastroenterology
• Others
Regional Insights- America: Due to its high incidence of inflammatory disorders, sophisticated healthcare system, and active R&D, America leads the world market for anti-inflammatory pharmaceuticals. Due to its substantial patient population and presence in the pharmaceutical business, the United States holds a substantial percentage of the market. Europe: Europe is a major market for anti-inflammatory medicines, with the UK, France, and Germany having the highest levels of healthcare spending and research. The demand for anti-inflammatory medicines is driven by the region's ageing population, increasing illness load, and emphasis on evidence-based therapy. Asia-Pacific: Driven by rapidly urbanizing populations, the Asia-Pacific region offers significant potential for market expansion.

3. Americas
• United States
• Canada
• Mexico
• Brazil
4. APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
5. Europe
• Germany
• France
• UK
• Italy
• Russia
6. Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Competitive Landscape: The top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounting for 21.59% market share. Other players accounted for 14.20%, 5.43%, and 5.32% including Johnson & Johnson, Amgen Inc., and AstraZeneca PLC. The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
• AbbVie
• Johnson & Johnson
• Amgen Inc
• AstraZeneca PLC
• Pfizer, Inc
• Novartis
• Roche
• Merck
• Sanofi
• GlaxoSmithKline
• Sun Pharmaceutical Industries Ltd
• TEVA

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti-inflammatory Therapeutics Market Size 2019-2030
2.1.2 Anti-inflammatory Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Anti-inflammatory Therapeutics Segment by Type
2.2.1 Anti-inflammatory Biologics
2.2.2 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
2.2.3 Corticosteroids
2.2.4 Others
2.3 Anti-inflammatory Therapeutics Market Size by Type
2.3.1 Anti-inflammatory Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Anti-inflammatory Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Anti-inflammatory Therapeutics Segment by Application
2.4.1 Arthritis
2.4.2 Respiratory Diseases
2.4.3 Dermatology
2.4.4 Gastroenterology
2.4.5 Others
2.5 Anti-inflammatory Therapeutics Market Size by Application
2.5.1 Anti-inflammatory Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Anti-inflammatory Therapeutics Market Size Market Share by Application (2019-2024)
3 Anti-inflammatory Therapeutics Market Size by Player
3.1 Anti-inflammatory Therapeutics Market Size Market Share by Players
3.1.1 Global Anti-inflammatory Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Anti-inflammatory Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Anti-inflammatory Therapeutics by Regions
4.1 Anti-inflammatory Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Anti-inflammatory Therapeutics Market Size Growth (2019-2024)
4.3 APAC Anti-inflammatory Therapeutics Market Size Growth (2019-2024)
4.4 Europe Anti-inflammatory Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Anti-inflammatory Therapeutics Market Size Growth (2019-2024)
5 Americas
5.1 Americas Anti-inflammatory Therapeutics Market Size by Country (2019-2024)
5.2 Americas Anti-inflammatory Therapeutics Market Size by Type (2019-2024)
5.3 Americas Anti-inflammatory Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-inflammatory Therapeutics Market Size by Region (2019-2024)
6.2 APAC Anti-inflammatory Therapeutics Market Size by Type (2019-2024)
6.3 APAC Anti-inflammatory Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Anti-inflammatory Therapeutics by Country (2019-2024)
7.2 Europe Anti-inflammatory Therapeutics Market Size by Type (2019-2024)
7.3 Europe Anti-inflammatory Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anti-inflammatory Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Anti-inflammatory Therapeutics Market Forecast
10.1 Global Anti-inflammatory Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Anti-inflammatory Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Anti-inflammatory Therapeutics Forecast
10.1.3 APAC Anti-inflammatory Therapeutics Forecast
10.1.4 Europe Anti-inflammatory Therapeutics Forecast
10.1.5 Middle East & Africa Anti-inflammatory Therapeutics Forecast
10.2 Americas Anti-inflammatory Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Anti-inflammatory Therapeutics Market Forecast
10.2.2 Canada Anti-inflammatory Therapeutics Market Forecast
10.2.3 Mexico Anti-inflammatory Therapeutics Market Forecast
10.2.4 Brazil Anti-inflammatory Therapeutics Market Forecast
10.3 APAC Anti-inflammatory Therapeutics Forecast by Region (2025-2030)
10.3.1 China Anti-inflammatory Therapeutics Market Forecast
10.3.2 Japan Anti-inflammatory Therapeutics Market Forecast
10.3.3 Korea Anti-inflammatory Therapeutics Market Forecast
10.3.4 Southeast Asia Anti-inflammatory Therapeutics Market Forecast
10.3.5 India Anti-inflammatory Therapeutics Market Forecast
10.3.6 Australia Anti-inflammatory Therapeutics Market Forecast
10.4 Europe Anti-inflammatory Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Anti-inflammatory Therapeutics Market Forecast
10.4.2 France Anti-inflammatory Therapeutics Market Forecast
10.4.3 UK Anti-inflammatory Therapeutics Market Forecast
10.4.4 Italy Anti-inflammatory Therapeutics Market Forecast
10.4.5 Russia Anti-inflammatory Therapeutics Market Forecast
10.5 Middle East & Africa Anti-inflammatory Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Anti-inflammatory Therapeutics Market Forecast
10.5.2 South Africa Anti-inflammatory Therapeutics Market Forecast
10.5.3 Israel Anti-inflammatory Therapeutics Market Forecast
10.5.4 Turkey Anti-inflammatory Therapeutics Market Forecast
10.5.5 GCC Countries Anti-inflammatory Therapeutics Market Forecast
10.6 Global Anti-inflammatory Therapeutics Forecast by Type (2025-2030)
10.7 Global Anti-inflammatory Therapeutics Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Anti-inflammatory Therapeutics Product Offered
11.1.3 AbbVie Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Anti-inflammatory Therapeutics Product Offered
11.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 Amgen Inc
11.3.1 Amgen Inc Company Information
11.3.2 Amgen Inc Anti-inflammatory Therapeutics Product Offered
11.3.3 Amgen Inc Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Amgen Inc Main Business Overview
11.3.5 Amgen Inc Latest Developments
11.4 AstraZeneca PLC
11.4.1 AstraZeneca PLC Company Information
11.4.2 AstraZeneca PLC Anti-inflammatory Therapeutics Product Offered
11.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 AstraZeneca PLC Main Business Overview
11.4.5 AstraZeneca PLC Latest Developments
11.5 Pfizer, Inc
11.5.1 Pfizer, Inc Company Information
11.5.2 Pfizer, Inc Anti-inflammatory Therapeutics Product Offered
11.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Pfizer, Inc Main Business Overview
11.5.5 Pfizer, Inc Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Anti-inflammatory Therapeutics Product Offered
11.6.3 Novartis Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Roche
11.7.1 Roche Company Information
11.7.2 Roche Anti-inflammatory Therapeutics Product Offered
11.7.3 Roche Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Roche Main Business Overview
11.7.5 Roche Latest Developments
11.8 Merck
11.8.1 Merck Company Information
11.8.2 Merck Anti-inflammatory Therapeutics Product Offered
11.8.3 Merck Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Merck Main Business Overview
11.8.5 Merck Latest Developments
11.9 Sanofi
11.9.1 Sanofi Company Information
11.9.2 Sanofi Anti-inflammatory Therapeutics Product Offered
11.9.3 Sanofi Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sanofi Main Business Overview
11.9.5 Sanofi Latest Developments
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Information
11.10.2 GlaxoSmithKline Anti-inflammatory Therapeutics Product Offered
11.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 GlaxoSmithKline Main Business Overview
11.10.5 GlaxoSmithKline Latest Developments
11.11 Sun Pharmaceutical Industries Ltd
11.11.1 Sun Pharmaceutical Industries Ltd Company Information
11.11.2 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product Offered
11.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Sun Pharmaceutical Industries Ltd Main Business Overview
11.11.5 Sun Pharmaceutical Industries Ltd Latest Developments
11.12 TEVA
11.12.1 TEVA Company Information
11.12.2 TEVA Anti-inflammatory Therapeutics Product Offered
11.12.3 TEVA Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 TEVA Main Business Overview
11.12.5 TEVA Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. Anti-inflammatory Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Anti-inflammatory Biologics
Table 3. Major Players of Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Table 4. Major Players of Corticosteroids
Table 5. Major Players of Others
Table 6. Anti-inflammatory Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Anti-inflammatory Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Anti-inflammatory Therapeutics Market Size Market Share by Type (2019-2024)
Table 9. Anti-inflammatory Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Anti-inflammatory Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Anti-inflammatory Therapeutics Market Size Market Share by Application (2019-2024)
Table 12. Global Anti-inflammatory Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Anti-inflammatory Therapeutics Revenue Market Share by Player (2019-2024)
Table 14. Anti-inflammatory Therapeutics Key Players Head office and Products Offered
Table 15. Anti-inflammatory Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Anti-inflammatory Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Anti-inflammatory Therapeutics Market Size Market Share by Regions (2019-2024)
Table 20. Global Anti-inflammatory Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Anti-inflammatory Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Anti-inflammatory Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Anti-inflammatory Therapeutics Market Size Market Share by Country (2019-2024)
Table 24. Americas Anti-inflammatory Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Anti-inflammatory Therapeutics Market Size Market Share by Type (2019-2024)
Table 26. Americas Anti-inflammatory Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Anti-inflammatory Therapeutics Market Size Market Share by Application (2019-2024)
Table 28. APAC Anti-inflammatory Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Anti-inflammatory Therapeutics Market Size Market Share by Region (2019-2024)
Table 30. APAC Anti-inflammatory Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Anti-inflammatory Therapeutics Market Size Market Share by Type (2019-2024)
Table 32. APAC Anti-inflammatory Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Anti-inflammatory Therapeutics Market Size Market Share by Application (2019-2024)
Table 34. Europe Anti-inflammatory Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Anti-inflammatory Therapeutics Market Size Market Share by Country (2019-2024)
Table 36. Europe Anti-inflammatory Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Anti-inflammatory Therapeutics Market Size Market Share by Type (2019-2024)
Table 38. Europe Anti-inflammatory Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Anti-inflammatory Therapeutics Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Anti-inflammatory Therapeutics Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Anti-inflammatory Therapeutics Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Anti-inflammatory Therapeutics Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Anti-inflammatory Therapeutics
Table 47. Key Market Challenges & Risks of Anti-inflammatory Therapeutics
Table 48. Key Industry Trends of Anti-inflammatory Therapeutics
Table 49. Global Anti-inflammatory Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Anti-inflammatory Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Anti-inflammatory Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Anti-inflammatory Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. AbbVie Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 54. AbbVie Anti-inflammatory Therapeutics Product Offered
Table 55. AbbVie Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. AbbVie Main Business
Table 57. AbbVie Latest Developments
Table 58. Johnson & Johnson Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 59. Johnson & Johnson Anti-inflammatory Therapeutics Product Offered
Table 60. Johnson & Johnson Main Business
Table 61. Johnson & Johnson Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Johnson & Johnson Latest Developments
Table 63. Amgen Inc Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 64. Amgen Inc Anti-inflammatory Therapeutics Product Offered
Table 65. Amgen Inc Main Business
Table 66. Amgen Inc Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Amgen Inc Latest Developments
Table 68. AstraZeneca PLC Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 69. AstraZeneca PLC Anti-inflammatory Therapeutics Product Offered
Table 70. AstraZeneca PLC Main Business
Table 71. AstraZeneca PLC Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. AstraZeneca PLC Latest Developments
Table 73. Pfizer, Inc Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 74. Pfizer, Inc Anti-inflammatory Therapeutics Product Offered
Table 75. Pfizer, Inc Main Business
Table 76. Pfizer, Inc Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Pfizer, Inc Latest Developments
Table 78. Novartis Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 79. Novartis Anti-inflammatory Therapeutics Product Offered
Table 80. Novartis Main Business
Table 81. Novartis Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Novartis Latest Developments
Table 83. Roche Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 84. Roche Anti-inflammatory Therapeutics Product Offered
Table 85. Roche Main Business
Table 86. Roche Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Roche Latest Developments
Table 88. Merck Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 89. Merck Anti-inflammatory Therapeutics Product Offered
Table 90. Merck Main Business
Table 91. Merck Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Merck Latest Developments
Table 93. Sanofi Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 94. Sanofi Anti-inflammatory Therapeutics Product Offered
Table 95. Sanofi Main Business
Table 96. Sanofi Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Sanofi Latest Developments
Table 98. GlaxoSmithKline Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 99. GlaxoSmithKline Anti-inflammatory Therapeutics Product Offered
Table 100. GlaxoSmithKline Main Business
Table 101. GlaxoSmithKline Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. GlaxoSmithKline Latest Developments
Table 103. Sun Pharmaceutical Industries Ltd Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 104. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product Offered
Table 105. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Sun Pharmaceutical Industries Ltd Main Business
Table 107. Sun Pharmaceutical Industries Ltd Latest Developments
Table 108. TEVA Details, Company Type, Anti-inflammatory Therapeutics Area Served and Its Competitors
Table 109. TEVA Anti-inflammatory Therapeutics Product Offered
Table 110. TEVA Main Business
Table 111. TEVA Anti-inflammatory Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. TEVA Latest Developments

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More

Buy Now

Safe and Secure SSL Encrypted

Quick Contacts

Want to customize this report?

We offer 10% Free Customization at the time of purchase

Get Free Customization

I'm Available

Anupriya Singh

Business Development Manager

Interested to schedule a FACE-TO-FACE meeting? Schedule a Call

Trusted Partners

Budget constraints? Get in touch with us for special pricing

Request Discount

Order Detail

Order Placed (22 January, 2025)
Notify To Team (22 January, 2025)
Report updation (23 January, 2025)
Report Quality Check (23 January, 2025)
Report Dispatch (24 January, 2025)

Email
Hard Copy

Research Methodology

An Adaptive Approach to Modern-day Research Needs

Get Methodology

Searching...

Global Anti-inflammatory Therapeutics Market Growth (Status and Outlook) 2024-2030

2024